Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	409	332	432	517	643	740
Market Cap Growth	-10.25%	-23.28%	-16.40%	-19.60%	-13.05%	54.90%
Enterprise Value	367	286	375	442	566	576
PE Ratio	-	-4.01	-29.10	125.13	-26.83	27.21
PS Ratio	2.42	1.99	2.77	3.50	4.93	6.46
PB Ratio	1.96	1.56	1.51	1.80	2.36	2.57
P/FCF Ratio	-91.06	-45.98	-140.54	158.96	56.25	21.65
P/OCF Ratio	240.30	-185.55	98.08	61.60	49.24	19.99
EV/Sales Ratio	2.17	1.71	2.40	2.99	4.34	5.03
EV/EBITDA Ratio	-4.93	-4.01	-122.41	23.72	-38.09	13.91
EV/EBIT Ratio	-4.12	-3.26	-19.33	169.07	-19.98	16.83
EV/FCF Ratio	-80.86	-39.61	-121.85	135.87	49.48	16.86
Debt / Equity Ratio	0.13	0.13	0.10	0.07	0.08	0.07
Debt / EBITDA Ratio	-0.39	-0.38	-9.41	1.03	-1.41	0.52
Debt / FCF Ratio	-6.36	-3.73	-9.37	5.91	1.83	0.63
Quick Ratio	3.54	3.50	4.33	4.17	3.32	12.78
Current Ratio	5.59	5.26	6.07	5.66	4.81	14.40
Asset Turnover	0.57	0.53	0.45	0.42	0.32	0.37
Interest Coverage	-	-	-	13.91	-93.78	-
Return on Equity (ROE)	-31.80%	-32.00%	-5.20%	1.40%	-8.40%	10.00%
Return on Assets (ROA)	-25.80%	-26.10%	-4.30%	1.20%	-5.90%	8.70%
Return on Capital (ROIC)	-34.12%	-36.64%	-6.17%	-10.28%	-19.43%	8.32%
Earnings Yield	-18.76%	-24.92%	-3.44%	0.80%	-3.73%	3.68%
FCF Yield	-1.01%	-2.17%	-0.71%	0.63%	1.78%	4.62%
Buyback Yield / Dilution	-0.31%	-0.65%	0.50%	-2.90%	1.06%	2.14%
Total Shareholder Return	-0.31%	-0.65%	0.50%	-2.90%	1.06%	2.14%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).